Skip to content
Search

Latest Stories

Coronavirus: Government announces £20m fund for vaccine research, launches public health campaign

Amid concerns over the ongoing novel coronavirus outbreak, the government has pledged £20m to develop new vaccines to combat the world’s deadliest diseases.

The new funding announced today will go to the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership between public, private, philanthropic, and civil society organisations launched in 2017 in response to the Ebola epidemic in West Africa.


It will support the development of new vaccines for epidemics including the novel coronavirus.

Health Secretary Matt Hancock said: “Vaccines are our best defence against a host of deadly diseases including coronavirus. The UK is a hub of world-leading and pioneering research, and it is vital that we lead the way in developing new vaccines to target global threats with scientists from across the world.”

“The £20 million announced today will help our globally recognised vaccine development capabilities continue to develop new defences against emerging diseases including coronavirus,” he said.

https://twitter.com/MattHancock/status/1224275091934060544

Welcoming the UK’s support and funding, CEPI said the rapid global spread and unique epidemiological characteristics of the virus were deeply concerning.

“Our hope is that, with our partners, we can get an investigational vaccine from gene sequencing of the pathogen through to clinical testing in 16 weeks. The earliest stage of clinical trials (Phase I), to establish the safety of investigational vaccines, would take around two to four months,” CEPI CEO Dr Richard Hatchett said.

Nation-wide campaign

The Department of Health and Social Care (DHSC) also launched a UK-wide campaign to provide clear advice to the public on how slow the spread of Coronavirus and reduce the impact on NHS services.

While two cases of Coronavirus have already been confirmed in the UK, the Health Secretary further assured that the NHS is well prepared to manage these types of incidents.

Similar to the 'Catch it, Bin it, Kill it' campaign used for flu and norovirus, the latest campaign will also promote important hygiene practices, such as regularly washing hands and always sneezing into a tissue, to stem the spread of viruses.

“Lots of people are asking what they can do to help stop the spread of the virus. Basic hygiene such as washing our hands regularly and using tissues when we cough and sneeze can play an important role in minimising the spread of viruses like this. Today we have launched a UK-wide advertising campaign to help the public protect themselves and each other," Hancock said in a separate statement.

More For You

Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less